MedTrace Logo

Investigating Pathological Mechanisms in Non-alcoholic Fatty Liver Disease

NCT04141592 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 153

Last updated 2025-06-03

No results posted yet for this study

Summary

To identify key characteristics of the tissue resident and peripherally circulating immune-phenotype in addition to blood markers, metabolic profile, faecal and oral microbiota in non-alcoholic fatty liver disease

Conditions

  • Non-Alcoholic Fatty Liver Disease

Interventions

PROCEDURE

Bariatric Surgery

Already clinically indicated surgical procedures

Sponsors & Collaborators

  • Homerton University Hospital NHS Foundation Trust

    collaborator OTHER

  • Barts & The London NHS Trust

    collaborator OTHER

  • King's College Hospital NHS Trust

    collaborator OTHER

  • Queen Mary University of London

    lead OTHER

Principal Investigators

  • William Alazawi, MD Phd · Queen Mary University of London

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-03-05
Primary Completion
2026-04-01
Completion
2026-04-01

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04141592 on ClinicalTrials.gov